JOURNAL OF PERINATAL MEDICINE is a reputable peer-reviewed journal published by Walter de Gruyter GmbH since 1973, with a steadfast commitment to advancing research in the fields of Obstetrics, Gynecology, Pediatrics, and Perinatology. With an impressive impact factor reflected by its Q2 quartile rankings in both Obstetrics and Gynecology and Pediatrics, this journal serves as a vital resource for professionals and researchers dedicated to improving maternal and child health outcomes. The journal's robust Scopus rankings, where it stands at 76th out of 330 in Pediatrics and 64th out of 209 in Obstetrics, further underscores its significant contribution to the academic community. Featuring cutting-edge research, clinical studies, and reviews, the JOURNAL OF PERINATAL MEDICINE strives to foster a deeper understanding of the complexities surrounding perinatal health while promoting interdisciplinary collaboration. Published in Germany, the journal remains accessible to a global audience, ensuring that essential findings are disseminated to drive innovation and best practices in the field.

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, published by Wiley, is a leading journal in the field of obstetrics and gynecology that has been disseminating high-quality research since its inception. With an ISSN of 1341-8076 and an E-ISSN of 1447-0756, this journal thrives on contributing to this specialized area of medicine, showcasing innovations and advancements essential for practitioners and scholars alike. Notably, it holds a commendable Impact Factor reflective of its Q2 ranking in both Medicine and Obstetrics and Gynecology categories for 2023, placing it in the 55th percentile among its peers according to Scopus. The journal covers a wide array of topics pertinent to contemporary medical practices and research in Australia and beyond, aiming to foster interdisciplinary dialogue and advance clinical practices. Researchers, professionals, and students will find it an invaluable resource, featuring rigorous peer-reviewed articles that shed light on emerging trends, clinical guidelines, and groundbreaking studies. As it continues to converge on pivotal medical issues up until 2024, JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH stands poised to make a lasting impact in the realm of women's health.

Therapeutic Advances in Reproductive Health, published by SAGE Publications Ltd, is an esteemed open-access journal dedicated to the field of reproductive health, with an E-ISSN of 2633-4941. Launched in 2020, the journal aims to disseminate cutting-edge research, novel therapeutic methodologies, and clinical applications related to reproductive health challenges. With an unwavering commitment to enhancing patient outcomes and advancing scientific understanding, it serves as a vital resource for researchers, healthcare professionals, and students alike. The journal emphasizes rigorous peer-reviewed content, ensuring high-quality publications that contribute significantly to the academic community. In an era where access to crucial health information is paramount, this open-access platform not only broadens the reach of research but also fosters collaboration and innovation in reproductive health.

ACTA Obstetricia et Gynecologica Scandinavica, published by Wiley, is a leading journal in the fields of obstetrics and gynecology, with its impressive history dating back to 1921. This esteemed journal holds a prestigious Q1 ranking in both Medicine (miscellaneous) and Obstetrics and Gynecology, positioning it in the top percentile of global research outputs according to Scopus. With an exceptionally high percentiles rank, #16 out of 209, it serves as a vital platform for researchers, practitioners, and students eager to contribute to and gain insights from cutting-edge studies impacting women's health. Although it does not currently provide open-access options, the journal’s rigorous peer-review process ensures that high-standard research reaches its diverse audience. By converging years of knowledge towards 2024, ACTA Obstetricia et Gynecologica Scandinavica continues to be essential in discussing contemporary issues and advancements in reproductive health, fostering significant scientific discourse and innovation.

CONTRACEPTION is a leading academic journal dedicated to advancing the field of reproductive health, published by Elsevier Science Inc. Since its inception in 1970, the journal has consistently provided a platform for high-quality research and insights in both Obstetrics and Gynecology and Reproductive Medicine, achieving notable recognition as a Q1 journal in these categories as of 2023. With an impact factor that underscores its significance—ranked #57 out of 209 in Obstetrics and Gynecology and #28 out of 90 in Reproductive Medicine according to Scopus—CONTRACEPTION is essential reading for researchers, clinicians, and students alike. The journal is committed to publishing innovative studies, review articles, and evidence-based guidelines that inform clinical practice and enhance patient care. Although it does not currently offer open access options, its comprehensive coverage of contemporary issues and empirical data makes it an invaluable resource for those invested in the future of reproductive healthcare.

The Journal of Obstetrics and Gynaecology Canada, published by Elsevier Inc., is a leading bi-monthly journal committed to advancing the fields of obstetrics and gynecology through high-quality research and clinical insights. With an impact factor positioned within the competitive Q2 category of the Obstetrics and Gynecology field as of 2023, this journal serves as a vital resource for researchers, clinicians, and students eager to stay informed about the latest developments. The journal is renowned for its rigorous peer-review process and dedication to disseminating innovative findings from 2002 to 2024. Currently ranked #92 out of 209 in Scopus' Medicine Obstetrics and Gynecology category, it falls within the 56th percentile of its peers. While it operates on a subscription basis, the contents are pivotal for professionals looking to enhance their practices and contribute to the ongoing discourse in maternal and women's health. For those dedicated to improving patient outcomes and advancing gynecological knowledge, the Journal of Obstetrics and Gynaecology Canada represents an invaluable platform.

Gynecology and Minimally Invasive Therapy (GMIT) is a distinguished open-access journal published by Wolters Kluwer Medknow Publications, focused on advancing the field of obstetrics and gynecology through innovative research and insights into minimally invasive techniques. With an ISSN of 2213-3070 and E-ISSN 2213-3089, GMIT has established itself as a prominent platform for researchers and clinicians alike, facilitating the dissemination of pivotal findings since its inception in 2012. The journal currently ranks in the Q3 category for Obstetrics and Gynecology in 2023, with a Scopus ranking of #120/209, placing it in the 42nd percentile within its field. Based in Mumbai, India, it has embraced open access since 2016, promoting the wide availability of groundbreaking research to enhance clinical practices and improve patient outcomes. GMIT aims to foster knowledge sharing and interdisciplinary collaboration, vital for professionals in the rapidly evolving landscape of gynecological care.

Obstetrical & Gynecological Survey, a leading journal in the fields of obstetrics and gynecology, is published by Lippincott Williams & Wilkins. With a history dating back to 1946, this esteemed journal provides a comprehensive platform for raising awareness and fostering advances in the health and clinical practices surrounding women's reproductive health. Its current rankings highlight its significance, placing it in the Q2 category for Obstetrics and Gynecology and Q3 for Medicine (miscellaneous) in 2023, with a Scopus rank of 105 out of 209. The journal aims to deliver high-quality, peer-reviewed articles on a diverse range of topics, including clinical studies, reviews, and innovative research, making it an essential resource for researchers, practitioners, and students in the field. Though it does not currently offer open access, the journal's impactful contributions continue to shape the dialogue and advancements within the specialty.

GEBURTSHILFE UND FRAUENHEILKUNDE is a prestigious journal dedicated to the fields of Maternity, Midwifery, Obstetrics, and Gynecology, published by GEORG THIEME VERLAG KG, a reputable publisher known for its commitment to advancing medical knowledge. Established in 1947, the journal has consistently provided a platform for high-quality research and clinical studies that address current challenges and innovations in women's health. With an impact factor positioned in Q2 for Maternity and Midwifery and Q3 in Obstetrics and Gynecology, it ranks among the top journals within its field, further solidified by its Scopus rankings highlighting its influential presence. Although the journal is not open access, it remains an essential resource for academics and practitioners keen to stay informed on the latest evidence-based practices and cutting-edge research, ensuring that all stakeholders in women's healthcare can access critical insights to enhance patient outcomes.

Facts Views and Vision in ObGyn is a vital academic journal dedicated to advancing the field of obstetrics and gynecology through innovative research and comprehensive reviews. Published by UNIVERSA PRESS, this journal serves as a platform for interdisciplinary dialogue among scholars, clinicians, and practitioners, contributing significantly to evidence-based practices in women's health. With an ISSN of 2032-0418, it offers a unique blend of original research articles, insights, and critical discussions aimed at addressing contemporary challenges and promoting best practices in ObGyn. Although it operates under a traditional access model, its commitment to quality content ensures a broad readership among healthcare professionals and academic institutions. The journal's importance is particularly underscored within clinical settings, where timely and reliable information can drive improvements in patient care and outcomes. Embrace the opportunity to engage with cutting-edge research that shapes the future of obstetrics and gynecology.